A. Krivine

发表

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients

G. Carcelain, A. Samri, C. Katlama, 2010, AIDS.

Evaluation of the One-Step Multiplex Real-Time Reverse Transcription-PCR ProFlu-1 Assay for Detection of Influenza A and Influenza B Viruses and Respiratory Syncytial Viruses in Children

P. Lebon, L. Bélec, F. Moulin, 2007, Journal of Clinical Microbiology.

A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus.

K. Mcintosh, M. Le May, V. Peña-Cruz, 1990, The Journal of pediatrics.

Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection.

E. Denamur, D. Lapierre, C. Rahimy, 1993, Journal of acquired immune deficiency syndromes.

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment.

O. Launay, S. Chhun, V. Jullien, 2009, The Journal of antimicrobial chemotherapy.

A case of congenital lymphocytic choriomeningitis virus (LCMV) infection revealed by hydrops fetalis

P. Lebon, F. Rozenberg, P. Loget, 2009, Prenatal diagnosis.

Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans

F. Carrat, E. Tartour, P. Lehmann, 2014, Human vaccines & immunotherapeutics.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

A. Samri, B. Autran, F. Carrat, 2014, The Journal of clinical investigation.

Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequences.

S. Benaboud, D. Salmon-Céron, B. Saka, 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy

S. Urien, N. Dupin, D. Salmon, 2008, Antimicrobial Agents and Chemotherapy.

Rhinoviruses as an underestimated cause of influenza‐like illness in pregnancy during the 2009–2010 influenza pandemic

V. Tsatsaris, F. Rozenberg, O. Launay, 2013, Journal of medical virology.

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.

F. Rozenberg, O. Launay, J. Huesler, 2012, Rheumatology.

Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome.

S. Hammer, R. Rose, A. Krivine, 1991, The American review of respiratory disease.

Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination

A. Samri, C. Katlama, F. Carrat, 2013, The Journal of Immunology.

VaccinationCompartments after Inactivated Influenza Effector and Memory Immune Longitudinal and Integrative Biomodeling of

Malka, A. Samri, C. Katlama, 2013 .

A cohort study of enfuvirtide immunological and virological efficacy in clinical practice

M. Pietri, P. Lebon, O. Launay, 2006, Journal of medical virology.

Predictive Factors of Cytomegalovirus Seropositivity among Pregnant Women in Paris, France

Y. Yazdanpanah, V. Tsatsaris, F. Rozenberg, 2014, PloS one.

Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.

F. Carrat, E. Tartour, G. Savoye, 2015, Journal of Crohn's & colitis.

Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.

C. Tournigand, F. Goldwasser, A. de Gramont, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant is required when using Env lipopeptide construct to induce HIV type 1-specific neutralizing antibody responses in mice in vivo.

J. Guillet, A. Tartar, H. Gras-masse, 1998, AIDS research and human retroviruses.

Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France

P. Vanhems, Y. Yazdanpanah, F. Carrat, 2016, Clinical Microbiology and Infection.

Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy

S. Urien, N. Dupin, A. Lillo-Le Louet, 2005, Antimicrobial Agents and Chemotherapy.

Testing for in utero human immunodeficiency virus infection with fetal blood sampling.

L. Mandelbrot, J. Aubin, M. Dommergues, 1996, American journal of obstetrics and gynecology.

Human Immunodeficiency Virus Type 1 (HIV-1) Detection by Polymerase Chain Reaction in Children of Infected Mothers

A. Krivine, 1992 .

Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples

Christoph Rudin, Marie-Louise Newell, Jack Moye, 2000, AIDS (London).

HIV replication during the first weeks of life

R. Henrion, C. Francoual, A. Krivine, 1992, The Lancet.

Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study

S. Grabar, O. Lortholary, O. Launay, 2008, Journal of acquired immune deficiency syndromes.

Long-term persistence of vaccine-induced HIV seropositivity in healthy volunteers.

L. Cuzin, J. Lelièvre, B. Silbermann, 2014 .

Long-Term Persistence of Vaccine-Induced HIV Seropositivity in Healthy

L. Cuzin, J. Lelièvre, B. Silbermann, 2014 .

Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patients

A. Seidowsky, H. François, S. Beaudreuil, 2011, Human vaccines.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study

V. Calvez, C. Charpentier, C. Delaugerre, 2017, The Journal of antimicrobial chemotherapy.

Viral kinetics in HIV-1 perinatal infection

A. Krivine, G. Firtion, P. Lebon, 1997, The Lancet.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease

B. Masquelier, H. Fleury, C. Rouzioux, 1996 .

Interferon and Aicardi-Goutières syndrome.

P. Lebon, F. Rozenberg, A. Krivine, 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex.

P. Lebon, F. Rozenberg, A. Cabée, 1999, Journal of neurovirology.

Clinical and Serologic Baseline and Follow-Up Features of Syphilis According to HIV Status in the Post-HAART Era

N. Dupin, M. Avril, P. Grange, 2009, Medicine.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2013, The Journal of antimicrobial chemotherapy.

Diagnostic antnatal des infections parvovirus B19

A. Krivine, 2003 .

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2010, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.

B. Masquelier, C. Rouzioux, D. Dormont, 1996, JAMA.

A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients

N. Dupin, O. Lortholary, O. Launay, 2009, Antiviral therapy.

Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen

D. Cabrol, V. Tsatsaris, O. Launay, 2008, Antiviral therapy.

[Measles and pregnancy].

V. Tsatsaris, F. Goffinet, O. Launay, 2011, Presse medicale.

Measles immunity and measles vaccine acceptance among healthcare workers in Paris, France.

F. Rozenberg, O. Launay, V. Dumaine, 2013, The Journal of hospital infection.

Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients.

L. Mouthon, O. Launay, P. Villiger, 2012, Clinical and experimental rheumatology.

Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.

B. Autran, J. Piette, L. Arnaud, 2011, Arthritis and rheumatism.

Does HIV-1 subtype D have a higher risk of vertical transmission than other HIV subtypes?

F. Rozenberg, O. Launay, V. Jullien, 2009, The Journal of infectious diseases.

Targeted HIV Screening in Eight Emergency Departments: The DICI‐VIH Cluster‐Randomized Two‐Period Crossover Trial

G. Verbeke, I. Durand-zaleski, G. Hejblum, 2017, Annals of emergency medicine.

HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen

V. Calvez, S. Yerly, L. Perrin, 2005, AIDS.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.

V. Calvez, N. Dupin, I. Gorin, 1997, AIDS.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Emergence of HIV-1 mutated strains after interruption of highly active antiretroviral therapy in chronically infected patients

W. Rozenbaum, S. Grabar, G. Pialoux, 2003, AIDS.

Persistence of Multidrug-Resistant HIV-1 without Antiretroviral Treatment 2 Years after Sexual Transmission

V. Calvez, C. Delaugerre, C. Katlama, 2003, Antiviral therapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study

Y. Ville, V. Tsatsaris, F. Rozenberg, 2012, PloS one.

Determinants of measles seroprevalence among pregnant women in Paris, France.

V. Tsatsaris, F. Rozenberg, F. Goffinet, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

B. Autran, A. Thiébaut, J. Bay, 2013, Vaccine.

Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis.

P. Böelle, P. Boelle, I. Sermet-Gaudelus, 2014, Vaccine.

Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantation.

A. Baruchel, M. Frémond, K. Yakouben, 2012, Human immunology.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Twelve Months of Routine HIV Screening in 6 Emergency Departments in the Paris Area: Results from the ANRS URDEP Study

C. Katlama, P. Nordmann, D. Costagliola, 2012, PloS one.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

A. Samri, B. Autran, F. Carrat, 2014, The Journal of clinical investigation.